![]() |
Management
of Early Rheumatoid Arthritis
|
Awareness of and vigilance for drug interactions is important, but concern about drug interactions should not prevent the prescription of drugs that are needed to reduce joint damage in early RA. Much more morbidity will accrue from leaving RA untreated than will occur as a result of these interactions.
Drug interactions with NSAIDs
| Drug | Effect of NSAID on drug | Principal mechanism* |
|
Antihypertensives |
Therapeutic effect decreased |
Sodium retention |
| Warfarin | Therapeutic effect increased |
Displaced protein binding |
| Sulphonylureas | Therapeutic effect increased | Displaced protein binding |
| Cyclosporin | Risk of nephrotoxicity increased | |
| Methotrexate | Therapeutic effect increased | Reduced renal clearance |
| Digoxin | Therapeutic effect increased | Reduced renal clearance |
| Lithium | Therapeutic effect increased | Reduced renal clearance |
| Phenytoin | Therapeutic effect increased | Displaced protein binding |
Risk of GI haemorrhage is
increased in patients on warfarin or corticosteroids. Further
interactions are listed in the British National Formulary, Appendix 1
58
* the mechanisms underlying drug interactions are complex
Drug interactions with DMARDs
| Drug | Interacts with |
| Azathioprine |
Allopurinol |
| Hydroxychloroquine |
Amiodarone |
| Cyclosporin | Multiple drugs, grapefruit juice |
| D-penicillamine |
Antacids, zinc, iron (including
proprietary indigestion tablets or mixtures) |
| Sulphasalazine | Digoxin |
| Methotrexate |
Aspirin/NSAIDs |
| Leflunomide |
Phenytoin |
| Minocycline |
Antacids, zinc, iron |
N.B. further interactions are listed in the British National Formulary, Appendix 1 58
| Web
contact: duncan.service@nhs.net Last modified 12/2/01 © SIGN 2001-2005 |